| Breakdown | Feb 2025 | Feb 2024 | Feb 2023 | Feb 2022 | Feb 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 452.68M | 442.10M | 396.72M | 327.15M | 188.51M |
| Gross Profit | 333.06M | 352.31M | 305.29M | 211.06M | 110.22M |
| EBITDA | 163.24M | 132.16M | 98.15M | 68.81M | 35.29M |
| Net Income | 79.81M | 58.35M | 33.99M | 21.22M | -11.90M |
Balance Sheet | |||||
| Total Assets | 699.65M | 660.25M | 681.93M | 653.17M | 643.00M |
| Cash, Cash Equivalents and Short-Term Investments | 59.70M | 76.76M | 91.08M | 57.34M | 68.50M |
| Total Debt | 261.95M | 158.58M | 153.11M | 153.54M | 153.49M |
| Total Liabilities | 495.29M | 377.51M | 369.92M | 362.53M | 383.51M |
| Stockholders Equity | 204.37M | 282.75M | 312.02M | 290.64M | 259.49M |
Cash Flow | |||||
| Free Cash Flow | 108.20M | 95.89M | 81.85M | -2.02M | 165.16M |
| Operating Cash Flow | 125.04M | 138.20M | 121.73M | 33.20M | 194.50M |
| Investing Cash Flow | -53.70M | -42.67M | -40.75M | -35.22M | -29.34M |
| Financing Cash Flow | -89.22M | -109.08M | -45.57M | -9.33M | -132.40M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | £1.99B | 1.18 | 24.73% | 1.18% | 7.17% | -2.22% | |
71 Outperform | £791.39M | 6.22 | 35.11% | ― | 2.40% | 48.36% | |
64 Neutral | £204.61M | -25.69 | 2.40% | 1.39% | -1.97% | -77.68% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
61 Neutral | £135.62M | 7.55 | 9.72% | 0.60% | 3.16% | -21.30% | |
50 Neutral | £1.25B | -21.38 | -65.76% | 2.50% | 4.58% | -24.15% | |
44 Neutral | £625.91M | -7.96 | -90.46% | 4.48% | -30.52% | -2064.92% |